Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

23 resultsUpdated October 25, 2026
1

Interferon-Driven Immune Dysregulation in Down Syndrome: A Review of the Evidence

Journal of Inflammation Research Volume 14 (2021)

Howard Chung; Peter H R Green; Timothy Cragin Wang; Xiao‐Fei Kong

2

A systematic review and meta-analysis of endocrine-related adverse events associated with interferon

Frontiers in Endocrinology 13 (2022)

Linghuan Wang; Binqi Li; He Zhao; Peixin Wu; Qingzhen Wu; Kang Chen; Yi-Ming Mu

3

Public health risk associated with the co-occurrence of mycotoxins in spices consumed in Sri Lanka

Food and Chemical Toxicology 74 (2014)

Pratheeba Yogendrarajah; Liesbeth Jacxsens; Carl K. Lachat; Chaminda Niroshan Walpita; Patrick Wilfried Kolsteren; Sarah De Saeger; Bruno De Meulenaer

5

Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: case report and literature review

The Brazilian Journal of Infectious Diseases 18(1) (2013)

Wenxue Zhao; Fanpu Ji; Shanshan Yu; Zongfang Li; Hong Xin Deng

6

Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan

BMC Endocrine Disorders 19(1) (2019)

Yu-Kang Chang; Yuan‐Tsung Tseng; Kou-Huang Chen; Kow‐Tong Chen; Kow‐Tong Chen; Kow‐Tong Chen

7

Thyroid Dysfunction in Chronic Hepatitis C Patients Treated with the Combined Pegylated Interferon-Ribavirin Therapy

Journal of Interferon & Cytokine Research 36(9) (2016)

Iman Hamza; Yara Mohamed Eid; Mohammad El-Sayed; Raghda N. Marzaban; Shaimaa Abdul-Kareem

9

Prevalence of thyroid disorders and the correlation of thyroid profile with liver enzymes, serum activin-A and follistatin during the treatment of patients with chronic hepatitis C genotype 1 and 4

Journal of Clinical and Experimental Investigations 5(3) (2014)

Bassem Refaat; Ahmad Mohammad Ashshi; Adel Galal El-Shemi; Adnan Alzanbagi

10

Thyroid disorders associated with hepatitis C or interferon based therapies

Journal of Microbiology and Infectious Diseases 03(03) (2013)

Şener Barut

11

Some Considerations About Cardiac Toxicity of Combination Therapy for Chronic Hepatitis C

Hepatitis Monthly 13(5) (2013)

Reza Karbasi-Afshar; Amin Saburi

12

Thyroid dysfunction among chronic hepatitis C patients and its relation to Interferon therapy

Journal of Current Medical Research and Practice 5(1) (2020)

MarwaA Mohammed; LobnaF El Toony; Lobna Abdel-Wahid Ahmed

13

Interferon-induced thyroid dysfunction: a case series

Endocrine Abstracts (2013)

DEVESH K. SENNIK; Daniel M. Forton; Leighton Seal

16

VIRAL HEPATITIS C PATIENTS; HYPOTHYROIDISM WITH RELATION OF INTERFERON TREATED PATIENTS

The Professional Medical Journal 23(10) (2016)

Aisha Rajput; Bagwan Das; Santosh Kumar; Rafique Ansari; Beshan Kumar; Abdul Qadeer

17

Frequency of Hypothyroidism in Patients with Hepatitis C on Standard Interferon Therapy

National Journal of Health Sciences 2(2) (2017)

Aijaz Zeeshan Khan Chachar; Khalid Mahmood Anjum; Arzinda Fatima; Nauman Tarif; Saleema Qaisera; Javed Iqbal M; Hafiz Muhammad Ahsan Khan

18

VIRAL HEPATITIS C PATIENTS

The Professional Medical Journal 23(10) (2016)

Aisha Rajput; Bagwan Das; Santosh Kumar; Rafique Ansari; Beshan Kumar; Abdul Qadeer

19

Frequency of Hypothyroidism in Chronic Hepatitis C patients treated with Standard Interferon Therapy

Pakistan BioMedical Journal 1(2) (2019)

Muhammad Farooq; Sami Ullah Mumtaz; Hina Akhtar; Kanza Ashraf; Tayyeba Komal; Irshad Hussain Qureshi

20

Neurological Impact of Type I Interferon Dysregulation

IntechOpen eBooks (2024)

Alessio Mylonas